A Phase 2b study of M1Pram in patients with type 1 diabetes and a BMI>30kg/m²
Latest Information Update: 27 Nov 2025
At a glance
- Drugs Insulin lispro/pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Oct 2025 According to an Adocia media release, The launch of this clinical trial is conditional on the signing of an agreement on the product.
- 19 Sep 2024 According to an Adocia media release, preparation for the Phase 2b clinical program in the United States, which plans to include 140 patients with type 1 diabetes and a BMI greater than 30 kg/m, is ongoing, and clinical batches have been manufactured.
- 06 Mar 2024 New trial record